StonvexLoading…
StonvexStonvexStonvexCore line items from LBRT's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q3 2026 (Est.) Expected 2026-07-22 | Q1 2023 2023-03-31 | Annual 2022 2022-12-31 | Q3 2022 2022-09-30 | Q2 2022 2022-06-30 |
|---|---|---|---|---|---|
Revenue | $1.08B | $1.23B | $4.00B | $2.83B | $1.71B |
Operating Income | Not available | $225.12M | $495.89M | $297.43M | $114.44M |
Net Income | Not available | $162.66M | $399.60M | $246.73M | $99.78M |
EPS (Diluted) | $-0.02 | $0.90 | $2.11 | $1.30 | $0.52 |
Total Assets | Not available | $2.76B | $2.58B | $2.53B | $2.34B |
Total Liabilities | Not available | $1.17B | $1.08B | $1.12B | $1.01B |
Cash & Equivalents | Not available | $20.88M | $43.68M | $24.05M | $41.48M |
Free Cash Flow OCF − CapEx | Not available | $70.80M | $78.46M | $-34.35M | $-89.11M |
Shares Outstanding | Not available | 181.09M | 189.35M | 190.47M | 190.62M |